In vivo evidence for a novel pathway of vitamin D3 metabolism initiated by P450scc and modified by CYP27B1

FASEB Journal

Volumn 26, Issue 9, 2012, Pages 3901-3915

  Slominski, Andrzej T ^a,e   Kim, Tae Kang ^a   Shehabi, Haleem Z ^b   Semak, Igor ^c   Tang, Edith K Y ^d   Nguyen, Minh N ^d   Benson, Heather A E ^b   Korik, Elena ^c   Janjetovic, Zorica ^a   Chen, Jianjun ^a   Yates, Charles R ^a   Postlethwaite, Arnold ^a   Li, Wei ^a   Tuckey, Robert C ^d  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b CURTIN UNIVERSITY   (Australia)

^c BELARUSIAN STATE UNIVERSITY   (Belarus)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e RM525 ^*  (United States)

Author keywords

20 hydroxyvitamin D; Adrenals; CYP11A1; Keratinocytes; Placenta

Indexed keywords

CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); COLECALCIFEROL; CYTOCHROME P450; CYTOCHROME P450 27B1; UNCLASSIFIED DRUG;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; KERATINOCYTE; MITOCHONDRION; NONHUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VITAMIN METABOLISM;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ANIMALS; CELLS, CULTURED; CHOLECALCIFEROL; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; KERATINOCYTES; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; TANDEM MASS SPECTROMETRY;

EID: 84865772160     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-208975     Document Type: Article

References (39)

1. Holick, M. F., Tian, X. Q., and Allen, M. (1995) Evolutionary importance for the membrane enhancement of the production of vitamin D3 in the skin of poikilothermic animals. Proc. Natl. Acad. Sci. U. S. A. 92, 3124-3126
2. Bikle, D. D. (2011) Vitamin D metabolism and function in the skin. Mol. Cell. Endocr. 347, 80-89
3. Holick, M. F. (2003) Vitamin D: A millennium perspective. J. Cell. Biochem. 88, 296-307
4. Holick, M. F. (2007) Vitamin D deficiency. N. Engl. J. Med. 357, 266-281
5. Plum, L. A., and DeLuca, H. F. (2010) Vitamin D, disease and therapeutic opportunities. Nat. Rev. Drug Discov. 9, 941-955
6. Bikle, D. D. (2008) Vitamin D receptor, UVR, and skin cancer: a potential protective mechanism. J. Invest. Dermatol. 128, 2357-2361
7. Slominski, A., Zjawiony, J., Wortsman, J., Semak, I., Stewart, J., Pisarchik, A., Sweatman, T., Marcos, J., Dunbar, C. C., and Tuckey, R. (2004) A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. Eur. J. Biochem. FEBS 271, 4178-4188
8. Slominski, A. T., Zmijewski, M. A., Semak, I., Sweatman, T., Janjetovic, Z., Li, W., Zjawiony, J. K., and Tuckey, R. C. (2009) Sequential metabolism of 7-dehydrocholesterol to steroidal 5,7-dienes in adrenal glands and its biological implication in the skin. PloS One 4, e4309
9. Guryev, O., Carvalho, R. A., Usanov, S., Gilep, A., and Estabrook, R. W. (2003) A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1). Proc. Natl. Acad. Sci. U. S. A. 100, 14754-14759
10. Slominski, A., Semak, I., Zjawiony, J., Wortsman, J., Li, W., Szczesniewski, A., and Tuckey, R. C. (2005) The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism. FEBS J. 272, 4080-4090
11. Tuckey, R. C., Li, W., Zjawiony, J. K., Zmijewski, M. A., Nguyen, M. N., Sweatman, T., Miller, D., and Slominski, A. (2008) Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc. FEBS J. 275, 2585-2596
12. Tuckey, R. C., Li, W., Shehabi, H. Z., Janjetovic, Z., Nguyen, M. N., Kim, T. K., Chen, J., Howell, D. E., Benson, H. A., Sweatman, T., Baldisseri, D. M., and Slominski, A. (2011) Production of 22-hydroxy-metabolites of vitamin D3 by cytochrome P450scc (CYP11A1) and analysis of their biological activities on skin cells. Drug Metab. Dispos. 39, 1577-1588
13. Tuckey, R. C., Janjetovic, Z., Li, W., Nguyen, M. N., Zmijewski, M. A., Zjawiony, J., and Slominski, A. (2008) Metabolism of 1alpha-hydroxyvitamin D3 by cytochrome P450scc to biologically active 1alpha,20-dihydroxyvitamin D3. J. Steroid Biochem. Mol. Biol. 112, 213-219
14. Slominski, A., Semak, I., Wortsman, J., Zjawiony, J., Li, W., Zbytek, B., and Tuckey, R. C. (2006) An alternative pathway of vitamin D metabolism. Cytochrome P450scc (CYP11A1)-mediated conversion to 20-hydroxyvitamin D2 and 17,20-dihydroxyvitamin D2. FEBS J. 273, 2891-2901
15. Nguyen, M. N., Slominski, A., Li, W., Ng, Y. R., and Tuckey, R. C. (2009) Metabolism of vitamin D2 to 17,20,24-trihydroxyvitamin D2 by cytochrome p450scc (CYP11A1). Drug Metab. Dispos. 37, 761-767
16. Tang, E. K., Li, W., Janjetovic, Z., Nguyen, M. N., Wang, Z., Slominski, A., and Tuckey, R. C. (2010) Purified mouse CYP27B1 can hydroxylate 20,23-dihydroxyvitamin D3, producing 1alpha,20,23-trihydroxyvitamin D3, which has altered biological activity. Drug Metab. Dispos. 38, 1553-1559
17. Slominski, A. T., Kim, T. K., Janjetovic, Z., Tuckey, R. C., Bieniek, R., Yue, J., Li, W., Chen, J., Nguyen, M. N., Tang, E. K., Miller, D., Chen, T. C., and Holick, M. (2011) 20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells. Am. J. Physiol. Cell Physiol. 300, C526-C541
18. Tang, E. K., Voo, K. J., Nguyen, M. N., and Tuckey, R. C. (2010) Metabolism of substrates incorporated into phospholipid vesicles by mouse 25-hydroxyvitamin D3 1alpha-hydroxylase (CYP27B1). J. Steroid Biochem. Mol. Biol. 119, 171-179
19. Slominski, A. T., Janjetovic, Z., Fuller, B. E., Zmijewski, M. A., Tuckey, R. C., Nguyen, M. N., Sweatman, T., Li, W., Zjawiony, J., Miller, D., Chen, T. C., Lozanski, G., and Holick, M. F. (2010) Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity. PloS One 5, e9907
20. Li, W., Chen, J., Janjetovic, Z., Kim, T. K., Sweatman, T., Lu, Y., Zjawiony, J., Tuckey, R. C., Miller, D., and Slominski, A. (2010) Chemical synthesis of 20S-hydroxyvitamin D3, which shows antiproliferative activity. Steroids 75, 926-935
21. Janjetovic, Z., Zmijewski, M. A., Tuckey, R. C., DeLeon, D. A., Nguyen, M. N., Pfeffer, L. M., and Slominski, A. T. (2009) 20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by increasing IkappaB alpha levels in human keratinocytes. PloS One 4, e5988
22. Zbytek, B., Janjetovic, Z., Tuckey, R. C., Zmijewski, M. A., Sweatman, T. W., Jones, E., Nguyen, M. N., and Slominski, A. T. (2008) 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation. J. Invest. Dermatol. 128, 2271-2280
23. Wang, J., Slominski, A., Tuckey, R. C., Janjetovic, Z., Kulkarni, A., Chen, J., Postlethwaite, A. E., Miller, D., and Li, W. (2012) 20-hydroxyvitamin D inhibits proliferation of cancer cells with high efficacy while being non-toxic. Anticancer Res. 32, 739-746
24. Tuckey, R. C. (2005) Progesterone synthesis by the human placenta. Placenta 26, 273-281
25. Tuckey, R. C., and Sadleir, J. (1999) The concentration of adrenodoxin reductase limits cytochrome p450scc activity in the human placenta. Eur. J. Biochem. 263, 319-325
26. Tuckey, R. C., Nguyen, M. N., Chen, J., Slominski, A. T., Baldisseri, D. M., Tieu, E. W., Zjawiony, J. K., and Li, W. (2012) Human cP450scc (CYP11A1) catalyses epoxide formation with ergosterol. Drug Metab. Dispos. 40, 436-444
27. Janjetovic, Z., Tuckey, R. C., Nguyen, M. N., Thorpe, E. M., Jr., and Slominski, A. T. (2010) 20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes. J. Cell. Physiol. 223, 36-48
28. Slominski, A. T., Li, W., Bhattacharya, S. K., Smith, R. A., Johnson, P. L., Chen, J., Nelson, K. E., Tuckey, R. C., Miller, D., Jiao, Y., Gu, W., and Postlethwaite, A. E. (2011) Vitamin D analogs 17,20S(OH)2pD and 17,20R(OH)2pD are noncalcemic and exhibit antifibrotic activity. J. Invest. Dermatol. 131, 1167-1169
29. Zehnder, D., Evans, K. N., Kilby, M. D., Bulmer, J. N., Innes, B. A., Stewart, P. M., and Hewison, M. (2002) The ontogeny of 25-hydroxyvitamin D(3) 1alpha-hydroxylase expression in human placenta and decidua. Am. J. Pathol. 161, 105-114
30. Ponchon, G., Kennan, A. L., and DeLuca, H. F. (1969) " Activation"of vitamin D by the liver. J. Clin. Invest. 48, 2032-2037
31. Tucker, G., 3rd, Gagnon, R. E., and Haussler, M. R. (1973) Vitamin D 3-25-hydroxylase: tissue occurrence and apparent lack of regulation. Arch. Biochem. Biophys. 155, 47-57
32. Yamamoto, K., Uchida, E., Urushino, N., Sakaki, T., Kagawa, N., Sawada, N., Kamakura, M., Kato, S., Inouye, K., and Yamada, S. (2005) Identification of the amino acid residue of CYP27B1 responsible for binding of 25-hydroxyvitamin D3 whose mutation causes vitamin D-dependent rickets type 1. J. Biol. Chem. 280, 30511-30516
33. Seino, Y., Tanaka, H., Yamaoka, K., and Yabuuchi, H. (1987) Circulating 1 alpha,25-dihydroxyvitamin D levels after a single dose of 1 alpha,25-dihydroxyvitamin D3 or 1 alpha-hydroxyvitamin D3 in normal men. Bone Min. 2, 479-485
34. Kubodera, N. (2009) D-hormone derivatives for the treatment of osteoporosis: from alfacalcidol to eldecalcitol. Mini Rev. Med. Chem. 9, 1416-1422
35. Slominski, A., Wortsman, J., Paus, R., Elias, P. M., Tobin, D. J., and Feingold, K. R. (2008) Skin as an endocrine organ: implications for its function. Drug Discov. Today Dis. Mech. 5, 137-144
36. Strushkevich, N., MacKenzie, F., Cherkesova, T., Grabovec, I., Usanov, S., and Park, H. W. (2011) Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system. Proc. Natl. Acad. Sci. U. S. A. 108, 10139-10143
37. Janjetovic, Z., Brozyna, A. A., Tuckey, R. C., Kim, T. K., Nguyen, M. N., Jozwicki, W., Pfeffer, S. R., Pfeffer, L. M., and Slominski, A. T. (2011) High basal NF-kappaB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives. Br. J. Cancer 105, 1874-1884
38. Zmijewski, M. A., Li, W., Zjawiony, J. K., Sweatman, T. W., Chen, J., Miller, D. D., and Slominski, A. T. (2009) Photo-conversion of two epimers (20R and 20S) of pregna-5,7-diene-3beta, 17alpha, 20-triol and their bioactivity in melanoma cells. Steroids 74, 218-228
39. Zmijewski, M. A., Li, W., Chen, J., Kim, T. K., Zjawiony, J. K., Sweatman, T. W., Miller, D. D., and Slominski, A. T. (2011) Synthesis and photochemical transformation of 3beta,21-dihy-droxypregna-5,7-dien-20-one to novel secosteroids that show anti-melanoma activity. Steroids 76, 193-203